https://sk.prisysbiotech.com/ Nie - Človek primát Výskum Platforma & CRO | PRISYS Biotech https://sk.prisysbiotech.com/uploads/39406/logo.png https://sk.prisysbiotech.com/translation-research/ Translačný výskum https://sk.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://sk.prisysbiotech.com/nhp-pharmacology/ Farmakológia NHP https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/safety-evaluation/ Hodnotenie bezpečnosti https://sk.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://sk.prisysbiotech.com/biosafety-research/ Výskum biologickej bezpečnosti https://sk.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://sk.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://sk.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://sk.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://sk.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://sk.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://sk.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://sk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://sk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://sk.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://sk.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://sk.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://sk.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://sk.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://sk.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://sk.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://sk.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://sk.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://sk.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://sk.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://sk.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://sk.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://sk.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://sk.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://sk.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://sk.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://sk.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://sk.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://sk.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://sk.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://sk.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://sk.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://sk.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://sk.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://sk.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://sk.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://sk.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://sk.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://sk.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://sk.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://sk.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://sk.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://sk.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://sk.prisysbiotech.com/pk-pd-adme/adme.html ADME https://sk.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://sk.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://sk.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://sk.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://sk.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://sk.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://sk.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://sk.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://sk.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://sk.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://sk.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://sk.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://sk.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://sk.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://sk.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://sk.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://sk.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://sk.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://sk.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://sk.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://sk.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://sk.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://sk.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://sk.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://sk.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://sk.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://sk.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://sk.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://sk.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://sk.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://sk.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://sk.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://sk.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://sk.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://sk.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://sk.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://sk.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://sk.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://sk.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://sk.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://sk.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://sk.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://sk.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://sk.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://sk.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://sk.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://sk.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://sk.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://sk.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://sk.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://sk.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://sk.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://sk.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://sk.prisysbiotech.com/translation-research/clinical-imaging.html Klinické zobrazovanie https://sk.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klinické zobrazovanie https://sk.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://sk.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://sk.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://sk.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://sk.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://sk.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Model diabetes mellitus 2 https://sk.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Model diabetes mellitus 2 https://sk.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://sk.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://sk.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://sk.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://sk.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://sk.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://sk.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://sk.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://sk.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://sk.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://sk.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://sk.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://sk.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://sk.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://sk.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://sk.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://sk.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://sk.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://sk.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://sk.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://sk.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://sk.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://sk.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://sk.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://sk.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://sk.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://sk.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://sk.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://sk.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://sk.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://sk.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://sk.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://sk.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://sk.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://sk.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://sk.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://sk.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://sk.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://sk.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://sk.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://sk.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://sk.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://sk.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://sk.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://sk.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://sk.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://sk.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://sk.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://sk.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://sk.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://sk.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://sk.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://sk.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://sk.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://sk.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://sk.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://sk.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://sk.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://sk.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://sk.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://sk.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://sk.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://sk.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://sk.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://sk.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://sk.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003172470432768.html Molekulárne zobrazovanie v modeloch NHP pre vývoj translačných liečiv https://sk.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://sk.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969955061588992.html Webinár NHP BehaviorAtlas|3D NHP Behavioral Tracking pre vývoj liekov https://sk.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://sk.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724350141391872.html Rekapitulácia z roku 2025: Ako Prisys predefinuje spoľahlivosť prekladu vo výskume NHP https://sk.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://sk.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17559595305804800.html NHP - Pharmakológia a farmacodynamické služby|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://sk.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530064929629184.html Zoznámte sa s Biotechom v nadchádzajúcom Roadshow EÚ: september 2025 https://sk.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://sk.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456023679214592.html Prisys Biotech-2025 Stredne rok preskúmanie https://sk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://sk.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243135370961920.html Zoznámte sa s Prisys v nadchádzajúcej americkej ceste v marci 2025 https://sk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://sk.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83978127.html Výročná správa PRISYS 2024: Pokrok v modeloch NHP a predklinickom výskume https://sk.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://sk.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77773013.html Prisys Biotech 2024 Newsletter Q2 – Vylepšený predklinický výskum a vývoj pre terapiu CNS s modelmi PRISYS s krížovou reakciou https://sk.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://sk.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028073085920256.html Prečo zvieracie modely uspejú alebo zlyhávajú vo vývoji liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021170993079296.html Kvantitatívne zapojenie PET cieľov do NHP pre lieky CNS https://sk.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://sk.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015428043351040.html Od videa k údajom: 3D sledovanie AI pre správanie NHP https://sk.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://sk.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015526528590848.html Zobrazovanie biodistribúcie PET u primátov (okrem človeka). https://sk.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://sk.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003172447216640.html PBPK vs. Kompartmentové modely: Prečo na PBPK záleží https://sk.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://sk.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993114039690240.html Rekapitulácia webinára: Pokrok vo výskume translačného NHP prostredníctvom digitálneho behaviorálneho fenotypovania https://sk.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://sk.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990428479038464.html Biomarkery PK v predklinickom vývoji liečiv|Expozícia – odozva a PK/PD https://sk.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://sk.prisysbiotech.com/news/behavior-in-rhesus-17985882551116800.html Spontánne sebapoškodzujúce-chovanie u makakov rhesus: translačný model NHP pre vývoj neuropsychiatrických liekov https://sk.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://sk.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17985882545005568.html Modely účinnosti MIDD a NHP pri vývoji translačných liekov https://sk.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://sk.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17977211318887424.html AI-Powered 3D NHP Behavioral Analysis|Behaviorálna fenotypizácia bez značiek https://sk.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://sk.prisysbiotech.com/news/webinar-nhp-behavioratlas-17977211459822592.html Globálny webinár|Kvantifikácia komplexného správania NHP: Predstavujeme Atlas správania NHP pre vysoko{0}}verné 3D behaviorálne fenotypovanie https://sk.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://sk.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969954904941568.html AI-Powered NHP Behavioral Analysis pre predklinický vývoj liečiv|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://sk.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17977211658183680.html Kedy zaviesť štúdie NHP pri vývoji autoimunitných liekov https://sk.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://sk.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17977212231214080.html Modely NHP IBD: Čo nás chronická enterokolitída u makakov rhesus učí o translačnom zápale čriev https://sk.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://sk.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17977211336303616.html MRI-Smerované podávanie AAV v modeloch mozgu NHP pre génovú terapiu CNS https://sk.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://sk.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17977212615451648.html Prečo na modeloch autoimunitných ochorení záleží na liekoch s pozitívnou kontrolou|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://sk.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17977211253351424.html Základný skríning ADA u umytých-opíc na predklinické biologické štúdie https://sk.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://sk.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969954762171392.html Mechanizmy bolesti: Model UVB spálenia je životne dôležitým translačným nástrojom https://sk.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://sk.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969954844353536.html Modely NHP vysoko{0}}tučnej diéty a programovania detskej obezity https://sk.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://sk.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17946834176320512.html Interpretácia klinickej patológie u psov a primátov (okrem človeka) v predklinických štúdiách https://sk.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://sk.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17946817792877568.html Molekulárne zobrazovacie biomarkery: Pokračovanie translačného výskumu a vývoja liekov https://sk.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://sk.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17946816981525504.html Čo je nelineárna farmakokinetika? Mechanizmy, charakteristiky a dôsledky pre vývoj liekov https://sk.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://sk.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17946817053320192.html Prečo je molekulárne zobrazovanie NHP rozhodujúce pre translačné PET štúdie https://sk.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://sk.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17946817037247488.html Čo je molekulárne zobrazovanie a prečo je dôležité pri vývoji liekov? https://sk.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://sk.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17946817067738112.html Štúdie biodistribúcie rádionuklidov NHP: Molekulárne zobrazovanie pre vývoj translačných liečiv https://sk.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://sk.prisysbiotech.com/news/nhp-heart-failure-model-17946817050436608.html Model srdcového zlyhania NHP podporuje translačný výskum génovej terapie obnovy telomér https://sk.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://sk.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17946817056187392.html Ako DSA a CTA Imaging zlepšujú hodnotenie kardiovaskulárnej bezpečnosti liekov https://sk.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://sk.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17946816935339008.html Model NHP arteriovenóznej skratovej trombózy u opíc Cynomolgus na hodnotenie translačného antitrombotického lieku https://sk.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://sk.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888417520935936.html Farmakokinetické údaje ako translačný biomarker https://sk.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://sk.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888417558045696.html Ne-modely pľúcnej fibrózy na primátoch: Pokrok v presnosti translácie pri vývoji liekov na dýchanie https://sk.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://sk.prisysbiotech.com/news/nhp-models-translational-drug-development-17888417474946048.html Prečo je vývoj liekov čoraz viac závislý od modelov NHP|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://sk.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888417847976960.html PK údaje ako farmakodynamický biomarker: Pokrok vo vývoji translačného liečiva prostredníctvom kvantitatívnej farmakológie https://sk.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://sk.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17853542501360640.html Farmakologické štúdie nespĺňajúce{0}}GLP na regulačné predloženie: Integrita údajov a laboratórne požiadavky https://sk.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://sk.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17853542607250432.html Strategický návrh neklinických farmakokinetických štúdií: od profilovania ADME k rozhodovaniu o preklade- https://sk.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://sk.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17853542417720320.html NHP AV-Model skratovej trombózy na hodnotenie bezpečnosti liekov|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://sk.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17853542177432576.html Čo je nelineárna farmakokinetika? Mechanizmy a translačné hodnotenie PK|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://sk.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17853542481404928.html Prisys Biotech podporuje IND schválenie UX-GIP001 FDA a CDE|NHP CNS doručovacia platforma https://img01.v15cdn.com/gallery/4x3/157.webp https://sk.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17853542460695552.html In vivo sledovanie imunitných buniek a vývoj PET indikátorov v modeloch NHP|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://sk.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17853542526100480.html Zobrazovanie PET transportéra dopamínu v modeloch NHP|CNS Imaging|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://sk.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17853542386721792.html Biodistribúcia PET/CT v modeloch NHP na podávanie liekov CNS|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://sk.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17853555986310144.html Veľká-platforma na rádioaktívne označovanie zvierat a zobrazovanie in vivo na vývoj translačných liekov https://sk.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://sk.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17853531718820864.html Prečo sa vývoj liekov čoraz viac spolieha na modely NHP: Základná úloha primátov v translačnej medicíne|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://sk.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17853531637441536.html Výzvy a riešenia IPF v oblasti vývoja liekov|Modely NHP s CT Imagingom a PFT https://sk.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://sk.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17853531534271488.html AI Markerless NHP 3D systém analýzy správania pre predklinický výskum https://sk.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://sk.prisysbiotech.com/news/evaluating-dmpk-properties-17853531576558592.html Hodnotenie vlastností DMPK kandidátskych zlúčenín pri včasnom objavovaní liekov|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://sk.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17853531569988608.html MRI-Guided CNS Delivery in NHP Models|Translačná platforma IMRI a CED https://sk.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://sk.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17853531837686784.html NHP CNS biodistribučné štúdie|Intratekálne podanie RNA|PRISYS Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://sk.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17853531864998912.html Translačný rámec PK/PD: Predikcia dávky opice Cynomolgus pre človeka|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://sk.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724350195835904.html Keď sa bolesť stane spomienkou: emocionálne faktory chronickej bolesti a výhoda modelu NHP|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://sk.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724350018692096.html Multi{0}}koncové hodnotenie bolesti: Budúcnosť vývoja analgetických liekov https://sk.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://sk.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724371153953792.html Prečo toľko analgetík zlyhá v predklinických skúškach? Odpoveď spočíva v tom, ako meriame bolesť https://sk.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://sk.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724350302905344.html Návrh časového bodu odberu krvi vo farmakokinetických (PK) štúdiách|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://sk.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724371412198400.html Štatistika PK: Parametre ne-kompartmentálnej analýzy (NCA) a predklinické aplikácie https://sk.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://sk.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724350191477760.html Prečo sú modely iných ako ľudských primátov kritické pre liečbu oligonukleotidov CNS https://sk.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://sk.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724350159479808.html Metabolizmus kyseliny močovej u ľudí a opíc: Translačné dôsledky pre vývoj liečiv https://sk.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://sk.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724350011859968.html Non-Mash primátov-model pridruženej fibrózy pečene|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://sk.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724350391755776.html Prečo je IMRI-riadené podávanie mozgových liekov nevyhnutné pre presné zacielenie v štúdiách NHP https://sk.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://sk.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674686245331968.html AI-Systém 3D analýzy správania bez značiek NHP|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://sk.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674686353286144.html Model NHP-indukovaný akútny zápal pľúc (ALI)|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://sk.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674686394409984.html HDM+SEB-Model indukovanej atopickej dermatitídy (AtD) u opíc Cynomolgus https://sk.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://sk.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674686327841792.html Jedno{0}} až viac{1}}priehradkové modely PK vysvetlené|Farmakokinetika NHP|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://sk.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674682319184896.html Ako si vybrať spoľahlivé predklinické CRO|Kľúčové kritériá pre biotechnologické spoločnosti|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://sk.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17677333901403136.html Prekladové hodnotenie CAR-T: Odbornosť in vitro a podpora štúdie NHP – Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://sk.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674697587778560.html Prečo viac ako 90 % kandidátov na lieky na CNS zlyhá v klinických skúškach? https://sk.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://sk.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674682511975424.html Predklinické modely Parkinsonovej choroby: Sprievodca výberom neurotoxínových, genetických a NHP modelov|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://sk.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674686179632128.html Vysoko presné{0}}dodávanie liekov a umelá inteligencia{1}riadené NHP prekladateľské platformy https://sk.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://sk.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17630673361347584.html Imunologické modely NHP riadené Th17|Translačný autoimunitný výskum v Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://sk.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17631382216664064.html Systém NHP BehaviorAtlas® založený na AI-|Platforma 3D behaviorálnej analýzy|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://sk.prisysbiotech.com/news/rfp-template-for-nhp-studies-17630671317230592.html Šablóna RFP pre štúdie NHP|Urýchliť efektivitu predklinického výskumu https://sk.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://sk.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17630671787729920.html Model bolesti studenej alodýnie u opíc Cynomolgus|Biotechnológie Prisys https://sk.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://sk.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17630672848413696.html MRI-Platforma na intracerebrálne podávanie liekov so sprievodcom|Prisys Biotech Výskum CNS https://sk.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://sk.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17630673926562816.html NHP modely respiračných chorôb a platforma na podávanie liekov v dýchacích cestách|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://sk.prisysbiotech.com/news/nhp-renal-biopsy-17630671382799360.html Platforma NHP renálnej biopsie a modely ochorení obličiek|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://sk.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17630671501878272.html PK štúdie a cielené podávanie liekov|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://sk.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17630671288542208.html Platforma NHP Research And AI-Bahavioral Analysis Platform spoločnosti Prisys Biotechnologies https://sk.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://sk.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17630671050957824.html Technológia podávania z nosa-do-mozgu (N2B) pre výskum CNS|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://sk.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17630671022351360.html SHR-2004: Prielom v prevencii VTE u pacientok s rakovinou vaječníkov – príbeh úspechu spoločnosti Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://sk.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540028019827712.html Modely opíc Cynomolgus & Rhesus|Prisys Biotech Predklinické CRO https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530064809026560.html Idiopatická pľúcna fibróza (IPF) NHP model|Prisys Biotech predklinické Cro https://sk.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://sk.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530064906806272.html Biodistribučné štúdie opice Cynomolgus|Prisys Biotech Predklinické CRO https://sk.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://sk.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530065020544000.html Prisys Biotech NHP Modely pre hematológiu a výskum mozgovej príhody https://sk.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://sk.prisysbiotech.com/news/the-importance-of-administration-volume-17530065070220288.html Dôležitosť objemu podania v predklinických štúdiách Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://sk.prisysbiotech.com/news/brain-targeted-drug-delivery-17530064994821120.html Dodávanie liečiva zamerané na mozog Prisys biotechnologický predklinický výskum NHP https://sk.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://sk.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530065022346240.html Vývoj liekov ADC|Translačný PK/PD rámec v predklinických štúdiách NHP https://sk.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://sk.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17501405372015616.html Modely bolesti NHP pre objavovanie translačných liekov Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://sk.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17501405348471808.html Sérum vs. Plazma: Výber optimálnej matrice pre predklinickú bioanalýzu https://sk.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://sk.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17501405326812160.html Pokyny pre predklinické dávkovanie: IV a PO objem, PH a osmolarita pre presnú PK u NHP a iných druhov https://sk.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://sk.prisysbiotech.com/news/nhp-copd-model-17501405321257984.html Najlepšie modely výskumu CHOCHP a vynikajúca platforma dýchacích ciest od Prisys https://sk.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://sk.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17501405144146944.html Model akútneho krvácania NHP: Kľúčový nástroj na urýchlenie nového vývoja liečiv hematológie https://sk.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://sk.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17501405140804608.html Výskum s pruritus: Prisys Biotech's IL-31-indukovaný model NHP na hodnotenie anti-pitchových terapií https://sk.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://sk.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456023204144128.html Sprievodca hodnotením anti-liekových protilátok (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456036290831360.html Respiračné terapie: Integrovaná platforma NHP spoločnosti Prisys Biotech pre predklinický výskum https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456023237043200.html Modely bolesti NHP: Zrýchlenie vývoja analgetického liečiva v biotechnológii Prisys https://sk.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://sk.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456023023821824.html Model platformy NHP na podporu vývoja liekov pri komplexných chorobách https://sk.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://sk.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456023868171264.html Kľúčové úvahy pre objem dávkovania, pH a zloženie na zvieracích modeloch https://sk.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://sk.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456023389479936.html Skonštruované exozómy: Revolučná dodávka liekov na poruchy CNS – predklinické poznatky od Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://sk.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456023109329920.html Hlavné princípy pre výber živočíšnych druhov v štúdiách toxikológie liekov na báze nukleových kyselín https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456023282541568.html Prisys Biotech DSA a IMRI pre štúdie hematologických, vaskulárnych a renálnych chorôb https://sk.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://sk.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456023134086144.html Modely bolesti opíc Cynomolgus: Podpora translačného výskumu pre prelomovú terapiu iónovými kanálmi https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456023287391232.html Výskum atopickej dermatitídy: Model NHP (NHP) Prisys Biotech's Non-Human (NHP) https://sk.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://sk.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456023202178048.html Prisys Biotech's NHP Atopic dermatitíd https://sk.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://sk.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374211182846976.html Navrhovanie štúdií na zvieratách: kľúčové úvahy pre úspech predklinického výskumu https://img01.v15cdn.com/gallery/4x3/300.webp https://sk.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374254581752832.html Atopická dermatitída: Ako modely opíc Cynomolgus vopred presnú terapeutiku https://sk.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://sk.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374210849088512.html Výskum astmy: Prečo-modely iných ako ľudských primátov sú kľúčové pre vývoj nových liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374210729976832.html Pochopenie farmakokinetiky antisense oligonukleotidu (ASO): kľúčové faktory absorpcie a distribúcie https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374211138315264.html Inhalačné štúdie NHP pre biologické látky: Špecializované predklinické CRO služby PRISYS https://img01.v15cdn.com/gallery/4x3/300.webp https://sk.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374210928452608.html Pokročilé predklinické inhalačné štúdie: Technické schopnosti a odbornosť v Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://sk.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374210850104320.html Pochopenie farmakokinetiky (PK): Kľúčové parametre a aplikácie vo vývoji liekov https://sk.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://sk.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374210928944128.html Intracerebroventrikulárna (ICV) injekcia: Presné podávanie CNS pre predklinický výskum https://sk.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://sk.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374210802934784.html Intracerebrálna (ICM) injekcia: Presné zacielenie na terapiu CNS – predklinické úvahy https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374210910725120.html Intratekálna (IT) injekcia: priama CNS podávacia cesta pre pokročilé terapie – predklinické úvahy https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374210814583808.html Pokrok vo výskume Parkinsonovej choroby pomocou modelu NHP https://img01.v15cdn.com/gallery/4x3/300.webp https://sk.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374254898865152.html Predklinické PK/PD štúdie a modely NHP pre vývoj liečiv|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://sk.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298492801639424.html Zameranie na interleukín-31 (IL-31): Nová hranica vo vývoji liekov na autoimunitné ochorenia – Prisys Biotech NHP modely pre predklinický výskum https://sk.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://sk.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295231345714176.html Neklinické hodnotenie imunotoxicity: stratégia, kľúčové úvahy a výber metódy https://img01.v15cdn.com/gallery/4x3/232.webp https://sk.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295197984531456.html Mikrobiálne testovanie a jeho vplyv na-neľudské primáty v predklinických štúdiách DMPK https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295198095647744.html Model endometriózy opíc cynomolgus https://sk.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://sk.prisysbiotech.com/news/membranous-nephropathy-model-17295197923877888.html Vývoj liekov pre progresívnu membránovú nefropatiu (MN): Platforma modelu Cynomolgus Monkey od spoločnosti Prisys Biotech https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295231445066752.html Farmakokinetika inhalovaných liekov: Posun paradigmy od systémovej k pľúcnej expozícii https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/animal-models-for-womens-health-17295197933134848.html Prisys Biotech: Zvieracie modely pre terapiu zdravia žien https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295198227293184.html Svetový deň obezity Prisys Biotech NHP Metabolické modely: Pohodenie vývoja antiobezitných terapií novej generácie https://sk.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://sk.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295231344780288.html Prisys Biotech's Cynomolgus Monkey Psoriasis Model: Vyhodnotenie predklinického farmakodynamiky https://sk.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://sk.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295197902152704.html Integrácia farmakokinetiky a farmakodynamiky vo vývoji liekov https://sk.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://sk.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888417422238720.html Webinár na-vyžiadanie|Precízny most: MRI-riadené CED a preložiteľné modely NHP na podávanie liekov CNS https://sk.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://sk.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295197933872128.html Čo skutočne potvrdzuje dôkaz o koncepcii (PoC) vo vývoji liekov? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295197813433344.html Zvieracie modely|Výzvy a aplikácie pri vývoji modelu bolesti https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295198150992896.html Neklinický farmakodynamický výskum https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243135766635520.html Výber ideálneho-ľudského primáta pre toxikologické štúdie: Makak Cynomolgus, Makak Rhesus a Kosmáč https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81244378.html Cielená terapia Parkinsonovej choroby: prelom v reálnom čase-MRI-riadená transplantácia kmeňových buniek https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295231125021696.html Systémový lupus erythematosus (SLE) a úloha zvieracích modelov v terapeutickom vývoji https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295197883573248.html Non-Human Primátový model pre reumatoidnú artritídu (RA) https://sk.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://sk.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295197823656960.html Stereotaktické nástroje zvieracieho mozgu založené na 3D súradnicových systémoch https://sk.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://sk.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295198150468608.html Zvieracie modely na testovanie in vivo (1): Založenie a klasifikácia https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83977152.html Skúmanie možných ciest vstupu biologických látok do mozgu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977155.html Pokrok vo výskume reumatoidnej artritídy (RA) s modelmi primátov (okrem človeka). https://sk.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://sk.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977159.html Skúmanie zvieracích modelov pre účinnosť liekov na atopickú dermatitídu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977156.html Kritická úloha zvieracích modelov vo výskume ľudských chorôb https://sk.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://sk.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83977160.html Opičí model s deficitom parkinových génov odhaľuje nové mechanizmy a terapeutické ciele pre Parkinsonovu chorobu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977153.html Neklinický sprievodca vývojom liekov: Štúdie akútnej, subakútnej, subchronickej a chronickej všeobecnej toxicity https://sk.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://sk.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977158.html Inovatívna aplikácia liekov z nosa do mozgu (N2B): Obídenie hematoencefalickej bariéry https://sk.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://sk.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977157.html Príležitosti a výzvy miniprasiat ako neklinického veľkého druhu zvierat https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83052355.html Stratégie podávania liekov pri ochoreniach mozgu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83133673.html Intraoperačná navigácia MRI v reálnom{0}}čase: Podpora schválenia FDA prvej génovej terapie pre deficit AADC https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83052350.html Štúdie očnej toxicity očných kvapiek: Hodnotenie expozície lieku a bezpečnosti https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82739123.html Spoločnosť Prisys Biotech vytvorila model psoriázy opice Cynomolgus na urýchlenie vývoja liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82739138.html Komplexné modely ne{0}}ľudských primátov na výskum obličkových chorôb od Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82739116.html Komplexné predklinické hodnotenie bezpečnosti konjugátov-liekov (ADC) u-ľudských primátov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82739115.html Farmakokinetické hodnotenie konjugátov-liekov (ADC) u primátov, ktorým nie je človek{1} https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82739112.html Farmakodynamické hodnotenie ADC https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82739113.html Pochopenie DMPK liekov ADC https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82739135.html Pokrok vo vývoji liekov na báze nukleových kyselín a výskumných schopností spoločnosti Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82278031.html Pokroky v mRNA pľúcnych aplikačných systémoch a inovatívnych službách biotechnológie Prisys https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82739570.html Prečo bola Nobelova cena za fyziológiu alebo medicínu za rok 2024 udelená týmto dvom vedcom, ktorí študovali mikroRNA? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82739118.html Farmakokinetické (PK) úvahy pre lieky na centrálny nervový systém (CNS). https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656492.html Pokroky vo výskume CNS: MRI-kompatibilný systém vstrekovania mozgu a technológia CED spoločnosti Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://sk.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81244390.html Pokrok v terapeutických inováciách v oblasti krvácania a zrážania s modelom MCAO Cynomolgus Monkey https://sk.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://sk.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81244389.html DMPK Hodnotenie liekov centrálneho nervového systému (CNS). https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/animal-models-of-human-diseases-81244383.html Zvieracie modely ľudských chorôb https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81244379.html Inovácie v hodnotení bolesti: analýza správania riadená umelou inteligenciou- https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/china-experimental-monkey-industry-81244385.html História, súčasný stav, výzvy a príležitosti čínskeho experimentálneho opičieho priemyslu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/human-disease-animal-models-81244388.html Zvieracie modely ľudských chorôb: Rozhodujúci nástroj pre pokrok v biomedicínskom výskume https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81244376.html Význam predklinickej farmakodynamiky pri vývoji liečiv|Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://sk.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81244377.html Intranazálne podávanie v štúdiách na zvieratách https://sk.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://sk.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79487877.html Revolučný vývoj liekov CNS: PRISYS Biotech predstavuje technológiu IMRI https://sk.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://sk.prisysbiotech.com/news/convection-enhanced-delivery-81244375.html Advancing Precision Medicine: Convection-Technológia vylepšeného doručovania (CED) od Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://sk.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81244386.html Model chronickej obličkovej choroby (CKD) opice Cynomolgus spoločnosti Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://sk.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79553970.html Neklinické hodnotenie bezpečnosti podávania očných liekov pomocou makakov Cynomolgus https://sk.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://sk.prisysbiotech.com/news/compartment-pk-model-81244387.html Pochopenie kompartmentových a nekompartmentových{0}}modelov vo farmakokinetike https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81244380.html Pokročilé techniky podávania CNS u opíc Cynomolgus: Urýchlenie vývoja liekov na báze oligonukleotidov https://sk.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://sk.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79553996.html Zníženie používania primátov (okrem človeka) pri neklinických hodnoteniach bezpečnosti: Pohľady FDA a priemyslu https://sk.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://sk.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79554009.html LCMS Predklinická bioanalýza liekov na génovú terapiu-na báze LNP https://sk.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://sk.prisysbiotech.com/news/mrna-based-therapies-past-79553999.html Terapie založené na MRNA-: minulosť https://sk.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://sk.prisysbiotech.com/news/pk-strategies-of-pdc-79553957.html Stratégie farmakokinetickej štúdie peptidových{0}}konjugátov liečiv (PDC) https://sk.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://sk.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79553968.html Úloha AAV v génovej terapii: Imunitné reakcie a toxicita https://sk.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://sk.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79553981.html Optimalizované neklinické stratégie hodnotenia imunogenity https://sk.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://sk.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79554003.html Farmakodynamické (PD) hodnotenie génovej terapie https://sk.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://sk.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79553997.html Farmakokinetika a bioanalýza oligonukleotidových liečiv-(1) https://sk.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://sk.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79554005.html Farmakokinetika a bioanalýza oligonukleotidových liečiv: Absorpčná a plazmatická farmakokinetika (PK) charakteristiky https://sk.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://sk.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79554002.html Faktory, ktoré je potrebné zvážiť pre imunogenitu oligonukleotidových liečiv https://sk.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://sk.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79554011.html MRNA: Výkonný a všestranný nástroj na boj proti chorobám-Prisys-Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://sk.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79554004.html Čínski vedci ponúkajú nové stratégie na zvrátenie základných symptómov Parkinsonovej choroby https://sk.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://sk.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79553993.html Biotechnológia Prisys: Nové lipidové nanočastice na dodávanie MRNA u primátov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79553992.html Význam výskumu translačnej medicíny od základného výskumu po klinické štúdie https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79553994.html Hlavné faktory posudzované v analýze WOE https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79553990.html Ako dodať biologické látky do mozgu? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79553983.html Ako sa lieky pohybujú a menia v našom tele: Stručný úvod do farmakokinetiky https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79553985.html Ako rýchlejšie a bezpečnejšie vyvinúť nové lieky: Sprievodca predklinickými štúdiami DMPK https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79554000.html Pokyny pre skupinové ustajnenie pre laboratórne opice https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79553988.html Zásadná úloha experimentálnych opíc pri napredovaní vedeckého výskumu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79553995.html Pochopenie Macaca Fascicularis (Makaka Cynomolgus): Kľúčové vlastnosti a prínosy pre biomedicínsky výskum https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79553991.html Revolučná liečba metabolických chorôb: Pokroky a výzvy vo vývoji peptidových liečiv https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79553980.html Ako vyhodnotiť bezpečnosť kožných produktov pred klinickými skúškami? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79553989.html Významná úloha experimentálnych opíc pri vývoji inovatívnych liekov: Pohľad do biznisu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79553987.html Toxicita pečene ako kľúčový problém pre lieky SiRNA: Komplexná analýza Špecifickosť cieľa: Dvojsečný-meč SiRNA https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79553975.html Pokrok v terapii SiRNA: Prekonávanie výziev vo vývoji liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79553976.html Aplikačné vyhliadky génových liekov na báze lipidových nanočastíc https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79553986.html Kľúčové body pri navrhovaní stratégií pre ne-klinické štúdie na mladých zvieratách https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79553984.html Pohľad do zmyslových a behaviorálnych čŕt primátov, ktoré nie sú -ľudskými (NHP) https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79554232.html Otázky a odpovede týkajúce sa hodnotenia neklinickej štúdie https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/significance-principles-and-requirements-of-79554010.html Význam, princípy a požiadavky výskumu bezpečnosti farmakológie https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79553982.html Ako hodnotiť predklinickú farmakologickú účinnosť? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79554231.html Úvahy o ne{0}}klinických farmakologických štúdiách a hodnotení terapeutických liekov na ne-alkoholickú steatohepatitídu (NASH) https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79553971.html Pokrok vo výskume CNS a CGT: Prisys Biotechnologies https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79553978.html Pokyny na odber cerebrospinálnej tekutiny-od človeka primátov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79553979.html Úvahy o interpretácii údajov o klinickej patológii u-ľudských primátov (NHP) a psovitých šeliem https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79553966.html ​​​​​​Začlenenie hodnotenia bezpečnosti CNS do všeobecných toxikologických štúdií https://sk.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://sk.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79553977.html Ako vykonávať predklinické farmakologické/toxikologické hodnotenie ADC? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79553969.html ADME Insights for Oligonukleotid Drugs (1) - Absorpcia, distribúcia https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79553972.html ADME Insights for Oligonukleotid Drugs (2) - Metabolizmus a vylučovanie https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79553960.html Predklinické štúdie na zvieratách (1) - Druhy zvierat https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79553967.html Výzvy a stratégie interpretácie údajov klinickej patológie v predklinických štúdiách psov a primátov-okrem človeka https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79554007.html Predklinické štúdie na zvieratách (2) - Spôsoby a objemy podávania https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/mrna-based-therapies-present-79554006.html Terapie založené na MRNA-: súčasnosť https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79554008.html Terapie-založené na MRNA: Budúcnosť a výzvy https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79553998.html Stručný úvod o biologickej analýze génovej terapie https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79487880.html Opica Cynomolgus vo výskume očných liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79487882.html Translačné a krížové{0}}reaktívne štúdie s modelmi imunológie a zápalu NHP spoločnosti Prisys https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79204679.html Ne{0}}naivné NHP v predklinických skúškach: Nákladovo{1}}efektívne riešenie od Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/nhp-asthma-model-79204654.html Model astmy NHP: Posilnenie predklinických štúdií účinnosti liekov s Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79204681.html Pokrok v imunológii a výskume zápalov s modelmi makakov Cynomolgus - Biotechnológie Prisys https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79205153.html Priama dodávka oligonukleotidových liekov do CNS a bežné histopatologické zmeny https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79204660.html Model intra-cerebrovaskulárnej mozgovej príhody (ICH) od spoločnosti Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75177066.html Ne{0}}klinický farmakodynamický výskum: Základný aspekt vo vývoji liekov SiRNA https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77773010.html MRI-Presná lokalizácia centrálneho nervového systému so sprievodcom veľkých zvierat a systém podávania sa usadil v Prisys Biotech https://sk.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://sk.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77088582.html Inovatívne riešenia pre pokrokovú respiračnú terapiu https://sk.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://sk.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74814213.html Prisys: Pokrok v experimentovaní na zvieratách prostredníctvom štúdií makakov Cynomolgus https://sk.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://sk.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76220233.html Prisys dosiahol plnú akreditáciu od AAALAC International: míľnik v zabezpečovaní vysokých štandardov starostlivosti o laboratórne zvieratá. https://sk.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://sk.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74699554.html Pozdvihnutie terapií nukleovými kyselinami prostredníctvom špičkových-hranin s modelmi Prisys Biotech primátov (okrem človeka) https://sk.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://sk.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74216598.html Revolučné podávanie liekov CNS: Prisys a prísľub intratekálnej injekcie https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75177064.html Newsletter Prisys Biotech 2024 Q1 - váš spoľahlivý špecialista na štúdium primátov iných ako človek https://sk.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://sk.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73660212.html Ako ultrazvuková-riadená biopsia pečene vylepšuje makaky{1}}Výskum https://sk.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://sk.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73660632.html Pokyny pre celoživotné používanie primátov (okrem človeka) v biomedicínskom výskume: Perspektíva biotechnológie Prisys https://sk.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://sk.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73030727.html Primáty okrem človeka: Stručný úvod k ich biologickým charakteristikám https://sk.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://sk.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72712008.html Prehľad výstavy|Prisys Biotech zažiari na výročnom stretnutí Americkej spoločnosti pre neurovedu (SfN 2023) https://sk.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://sk.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72335916.html Zoznámte sa s Prisys Biotech na výročnom stretnutí Society For Neuroscience (SfN 2023) https://sk.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://sk.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72335915.html Svetový deň mŕtvice|Zamerajte sa na zvieracie modely ischemickej mŕtvice a farmakológiu https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72335912.html Prisys Biotech vás pozýva na výročné stretnutie SAPA-Čína v roku 2023 https://sk.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://sk.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72335913.html Svetový deň Alzheimerovej choroby|Výzvy a riešenia pre vývoj AD liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72336396.html Zvierací model makaka Cynomolgus spoločnosti Prisys Biotech pomáha pri vývoji nových antikoagulačných liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71078779.html Prisys: Poskytovanie vysoko{0}}kvalitnej služby na pokusy na zvieratách pre novú protilátku proti-koagulačnému faktoru XI BJTJ-1837 https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71078776.html Spôsob vytvorenia modelu opice Cynomolgus hypertriglyceridémie a jeho aplikácia https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71078781.html Farmakológia: Hlavné parametre a význam farmakokinetiky (PK) https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71078780.html Predklinické farmakologické hodnotenie onkolytických vírusových liekov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/0-71078777.html Ako môžu lieky s malými nukleovými kyselinami transformovať liečbu chorôb CNS: Postrehy od spoločnosti Prisys Biotechnology, poskytovateľa modelov chorôb NHP https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71078778.html Farmakokinetika, výskumné stratégie a prípadové štúdie peptidových liečiv https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69671096.html Kľúčové body výskumu ADC Drug PK https://img01.v15cdn.com/gallery/4x3/148.webp https://sk.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69670771.html Prisys Biotechnology: Líder vo výskumnej platforme modelovania chorôb CNS NHP https://sk.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://sk.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309379.html Ako schudnúť a kontrolovať cukrovku pomocou produktov GLP-1 https://sk.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://sk.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309270.html Ako China Monkey pomáha vykonávať predklinický výskum efektívnosti? https://sk.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://sk.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309271.html Aká je účinnosť RNAi? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309334.html Platforma verejnej služby Prisys Biotech pre experiment na veľkých zvieratách: Nízke-náklady a vysoká{1}}účinnosť riešenia pre experimenty na veľkých zvieratách https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69080634.html Ako môže AAV génová terapia zachrániť vašu víziu: Najnovšie objavy zo štúdií na primátoch, ktoré nie sú-u ľudí https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69086164.html Spoločnosť Prisys Biotech predvádza platformu-modelov primátov na výročnom stretnutí Japonskej toxikologickej spoločnosti https://sk.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://sk.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69082788.html Sľubná budúcnosť AAV génovej terapie u-neľudských primátov https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69089366.html Čo sú lipidové nanočastice pre génovú terapiu? https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69081160.html Prisys Biotech vás pozýva na účasť na 50. výročnom stretnutí Japonskej toxikologickej spoločnosti (JSOT) https://sk.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://sk.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69081651.html Test imunotoxicity, hodnotenie bezpečnosti liečiv-PRISYS BIOTECH https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68332360.html Optimálny zvierací model ischemickej cievnej mozgovej príhody stanovený digitálnou subtrakčnou angiografiou-Smerované autológne tromby u opíc Cynomolgus https://sk.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://sk.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68127531.html Prečo by ste sa mali zaujímať o-neľudské primáty vo výskume a vývoji systému na dodávanie liekov na báze nukleových kyselín https://sk.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://sk.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68127530.html Zoznámte sa s Prisys Biotech na 70. ročníku JALAS 2023! https://sk.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://sk.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68127532.html Génová terapia žiari novými schváleniami pre zriedkavé choroby https://sk.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://sk.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68127529.html Revolučný objav liekov: Ako primáty (okrem človeka) optimalizujú skríning siRNA pre rýchlejšie a efektívnejšie výsledky https://sk.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://sk.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67551582.html Maximalizácia farmakologickej účinnosti SiRNA pomocou výskumu primátov (okrem človeka). https://sk.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://sk.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67552229.html Ako môžu primáty (okrem človeka) priniesť revolúciu vo výskume SiRNA: Komplexný sprievodca https://sk.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://sk.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67571018.html Oslava Svetového dňa laboratórnych zvierat: Prečo sa Prisys zaviazal podporovať zdravie primátov (okrem človeka) https://sk.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://sk.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67565066.html Maximalizácia efektívnosti výskumu CRISPR/Cas9 s modelmi primátov (okrem človeka). https://sk.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://sk.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67552230.html Uvoľnenie terapeutického potenciálu: Prečo je investovanie do liekov na báze nukleových kyselín budúcnosťou medicíny https://sk.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://sk.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67593206.html Odomknutie potenciálu primátov (okrem človeka) pri zlepšovaní génovej terapie pri objavovaní cieľových liečiv https://sk.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://sk.prisysbiotech.com/news/world-parkinsons-disease-day-67582227.html Zjednoťte sa za Parkinsonovu chorobu: Spojte sa a zvýšte povedomie o Svetovom dni Parkinsonovej choroby https://sk.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://sk.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67571937.html Ako efektívne využívať-nečloveka primáty pri hodnotení bezpečnosti génovej terapie https://sk.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://sk.prisysbiotech.com/news/gene-therapy-toxicology-66275673.html Toxikologický výskum génovej terapie s primátom nonhuam https://sk.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://sk.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66154671.html Komplexný sprievodca vykonaním štúdie DMPK pre génovú terapiu https://sk.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://sk.prisysbiotech.com/news/gene-therapy-nhp-model-66154669.html Revolučný medicínsky výskum: Prelomy v génovej terapii v modeloch chorôb primátov (okrem človeka) https://sk.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://sk.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66154670.html Top 10 populárnych otázok súvisiacich s génovou terapiou https://sk.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://sk.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66154668.html Prisys Biotech: Ne-farmakológia primátov pre génovú terapiu https://sk.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://sk.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66154667.html Podpora zdravia žien: pohľad na endometriózu https://sk.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://sk.prisysbiotech.com/news/prisys-sot2023-66154663.html PRISYS a Taichu Group spolupracujú na výstave SOT v roku 2023 https://sk.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://sk.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66154666.html Potrebujeme ďalšie štúdie na hodnotenie bolesti? - NHP https://sk.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://sk.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66154664.html Pridajte sa k nám a oslávte Svetový deň divokej prírody https://sk.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://sk.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66154665.html Prisys Shanghai NHP R&D Center sa spúšťa, čo znamená míľnik vo farmaceutickom výskume a vývoji v Číne https://sk.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://sk.prisysbiotech.com/news/meetprisys-sot2023-66154662.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://sk.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg